SKIBSTED RUSSELL
SEC insider (Form 3/4/5 filer). CIK 0001308105. Chief Financial Officer at Processa Pharmaceuticals, Inc. (PCSA). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 26, 2026. Located in VERO BEACH, FL.
Companies SKIBSTED RUSSELL has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Officer, Chief Financial Officer
SKIBSTED RUSSELL
CIK: 0001308105
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Processa Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
11.9K shares- - Jun 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect3.3K shares at avg. $1.93$6K - Jun 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.7K shares at avg. $2.22$6K - May 29, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.3K shares at avg. $2.57$6K - May 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2K shares at avg. $2.97$6K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.2K shares at avg. $2.69$6K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2K shares at avg. $2.97$6K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.3K shares at avg. $2.54$6K - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
324K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
108K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 11,883 | - | - | Direct |
| Jun 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 3,277 | $1.93 | $6,325 | Direct |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,654 | $2.22 | $5,892 | Direct |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,292 | $2.57 | $5,890 | Direct |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,984 | $2.97 | $5,892 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,190 | $2.69 | $5,891 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,984 | $2.97 | $5,892 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,324 | $2.54 | $5,891 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 324,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 108,000 | - | - | Direct |
1-10 of 11 transactions